Did you know that Valley Fever is more prevalent in Arizona than any other state? Dr. John Galgiani, a Tucson infectious disease specialist and a leading expert on Valley Fever, will give a lecture about this disease at 3:30 p.m. Thursday (Nov. 12) in the Arizona Senior Academy’s Great Room.
Entitled “Valley Fever 101: Where Do We Go from Here?” the lecture begins at 3:30 p.m. in the Great Room of the ASA Building. Galgiani will describe Valley Fever, how significant its impact is on Arizona, and approaches to reduce its impact with better medical management, new treatments and vaccines.
A 1972 graduate of Stanford University, Galgiani received his M.D. from Northwestern Medical School. Before moving to Tucson in 1978 to join the University of Arizona faculty, he was a Fellow in Infectious Diseases at Stanford and Chief Resident in Internal Medicine at Pacific Medical Center, San Francisco.
Galgiani has focused his career on Arizona’s special problems with Valley Fever, including studies of its impact on the general population and on specific groups such as organ transplant patients and those with AIDS. He has been project director of a clinical trials group evaluating new therapies for Valley Fever that discovered and patented a recombinant antigen that is the basis for a potential vaccine. He recently became the project leader for developing a new Valley Fever drug for which clinical trials are underway. He is Chief Medical Officer of Valley Fever Solutions Inc., a start-up company founded to assist in the drug’s development.
In 1996 the Arizona Board of Regents accepted Galgiani’s proposal to establish the Valley Fever Center for Excellence for Arizona universities, based at the University of Arizona, for which he serves as director. The center maintains a website http://www.vfce.arizona.edu/ and answers questions from health care professionals around the world.
Written by H. Deon Holt, Academy Village Volunteer
[box type=”info”] Interested in attending? Click here.[/box]